Harmony Biosciences Holdings

Harmony Biosciences Secures FDA Orphan Drug Designation for Pitolisant in Prader-Willi Syndrome Treatment

PLYMOUTH MEETING, PA — The U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to Harmony Biosciences Holdings, Inc.’s (Nasdaq: HRMY) pitolisant for the treatment of Prader-Willi syndrome …

Harmony Biosciences Secures FDA Orphan Drug Designation for Pitolisant in Prader-Willi Syndrome Treatment Read More

North Bay Resources

North Bay Resources Inc. Announces High-Grade Copper Assays and Upcoming Exploration at Copper Island Project

SKIPPACK, PA — North Bay Resources Inc. (OTC: NBRI), a Pennsylvania-based mineral exploration company, recently unveiled promising assay results from its Red-Bed Copper Project at Copper Island, British Columbia, Canada. …

North Bay Resources Inc. Announces High-Grade Copper Assays and Upcoming Exploration at Copper Island Project Read More